Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    23024237 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)
Condition: Adult Acute Lymphocytic Leukemia
Interventions: Drug: Cyclophosphamide;   Drug: Dexamethasone;   Drug: Vincristine;   Drug: daunorubicin;   Drug: Asparaginase;   Drug: Methotrexate;   Drug: Cytarabine;   Drug: Mercaptopurine;   Drug: G-CSF;   Drug: Vindesine;   Drug: VP16;   Drug: Prednisolone;   Drug: Adriamycin;   Drug: Thioguanine;   Drug: VM26;   Procedure: CNS irradiation;   Procedure: Mediastinal Irradiation;   Procedure: Stem cell transplantation;   Drug: Idarubicin;   Drug: Fludarabine;   Drug: Cladribine
2 Unknown  German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Condition: Adult Acute Lymphocytic Leukemia
Interventions: Drug: Cyclophosphamide;   Drug: Dexamethasone / Prednisolone;   Drug: Cytarabine;   Drug: Idarubicin;   Drug: Granulocyte-Colony-Stimulating Factor;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Rituximab;   Drug: HDARAC;   Drug: Vincristine;   Drug: Depocyte;   Drug: Asparaginase

Indicates status has not been verified in more than two years